WilmerHale Recognized in Nearly All Areas Covered by LMG Life Sciences Legal Directory, Earning the Life Cycle Firm for the Ninth Consecutive Year

WilmerHale Recognized in Nearly All Areas Covered by LMG Life Sciences Legal Directory, Earning the Life Cycle Firm for the Ninth Consecutive Year

Recognition

The 2021 edition of LMG Life Sciences United States has recognized WilmerHale and 20 of its lawyers among the nation’s leading life sciences law firms and lawyers. In addition to the categories below, the firm received the notable “Life Cycle” distinction. This award recognizes firms with significant practices in nearly all areas covered by LMG Life Sciences. WilmerHale has received this esteemed recognition every year since the first edition of LMG Life Sciences in 2012.

The firm was recognized eight categories, including:

Corporate

Corporate – Highly Recommended

Licensing & Collaboration – Highly Recommended

Mergers & Acquisitions – Recommended

Venture Capital – Recommended

Intellectual Property

General Patent Litigation – Highly Recommended

Hatch-Waxman Patent Litigation – Highly Recommended

Patent Strategy & Management - Recommended

Non-IP Litigation

White-Collar/Government Investigations – Highly Recommended

The firm’s individual 2021 life sciences “stars” include:

Steven Barrett

David Bassett

Michael Bongiorno

Alyssa DaCunha

Lia Der Marderosian

Stuart Falber

Robert Gunther

Brent Gurney

Sarah Hogan

Stephen Jonas

Bill Lee

Bruce Manheim

Cynthia Mazareas

Lisa Pirozzolo

Emily Schulman

Mark Selwyn

Howard Shapiro

Colleen Superko

Emily Whelan

Amy Wigmore

To view all rankings, visit the firm and individual rankings on LMG Life Sciences’ website.


Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.